Unfavorable effects of memantine on the skeletal system in female rats

• Published in: Biomedicine & pharmacotherapy 2023-08, Vol.164, p.114921-114921, Article 114921
• Main Authors: Londzin, Piotr, Cegieła, Urszula, Trawczyński, Marcin, Czuba, Zenon P., Folwarczna, Joanna
• Format: Article
• Language: English
• Subjects: Animals; Bone and Bones; Bone Density; Estrogen deficiency; Estrogens - pharmacology; Female; Humans; Memantine; Memantine - pharmacology; Musculoskeletal system; Osteoporosis; Ovariectomy; Rats; Rats, Wistar
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2023.114921

Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist used in the treatment of Alzheimer's disease (AD). NMDA receptors are expressed on bone cells. The aim of the present study was to investigate the effects of memantine on the rat musculoskeletal system. Taking into account that most of female AD patients are postmenopausal, the study was carried out on intact and ovariectomized (estrogen-deficient) rats. Mature Wistar rats were divided into following groups: non-ovariectomized (NOVX) control rats, NOVX rats treated with memantine, ovariectomized (OVX) control rats, and OVX rats treated with memantine. Memantine (2 mg/kg p.o.) was administered once daily for four weeks, starting one week after ovariectomy. The serum bone turnover marker and cytokine levels, bone density, mass, mineralization, mechanical properties, histomorphometric parameters of compact and cancellous bone, skeletal muscle mass and grip strength were determined. In NOVX rats, memantine slightly decreased the strength of compact bone of the femoral diaphysis (parameters in the yield point) and unfavorably affected histomorphometric parameters of cancellous bone (the femoral epiphysis and metaphysis). In OVX rats, in which estrogen deficiency induced osteoporotic changes, memantine increased the phosphorus content in the femoral bone mineral. No other effects on bone were observed in the memantine-treated OVX rats. In conclusion, the results of the present study indicated slight damaging skeletal effects of memantine in rats with normal estrogen levels. •Memantine unfavorably affected bones in rats with normal estrogen levels.•Memantine slightly worsened cancellous bone microstructure and compact bone strength.•Memantine did not affect most of bone parameters in estrogen-deficient rats.•The results indicate the possibility of adverse skeletal effects of memantine.